Page 67 - Sohini Das

Biocon Biologics' antibody drug unit in Bengaluru gets EU GMP certificate

Approval comes from Irish health regulator, which had flagged some deficiencies in the manufacturing process iin May

StanPlus aiming under-10-minute arrival time for an ambulance in one year

Managing a fleet of close to 3,000 ambulances, StanPlus now claims to dispatch ambulances in under four minutes and reach the patient in under 15 minutes

Covid-19: Four states post double-digit test positivity ratios, shows data

Many other states have had Covid-19 cases doubling over the latest week

Covid-19: Experts bat for mixing vaccines in the wake of BA.2.75 variant

Senior research fellow at Oxford say BA.2.75 has several mutations in the spike protein, two of which are unique to it when compared to its parent strain BA.2

Research-linked incentive scheme in works for pharmaceutical industry

15% turnover investment in research could make companies eligible for the scheme

Health ministry takes steps to boost compliance as corruption cases surface

The CDSCO is planning to monitor visitors to any of its officials closely

Our Caribbean ops bring us close to US mkt: Narayana Health's Viren Shetty

In a Q&A, the executive vice-chairman of the hospital chain dwells on lessons from the pandemic, says hospital industry has always been dollar-exposed and thus had pressure on margins

How is Viren Shetty taking Narayana Health biz close to US shores?

In a chat with Business Standard's Sohini Das, executive vice-chairman of Narayana Health, Viren Shetty tells about expansion plans within and outside India, and lessons learnt during the pandemic

India's first mRNA Covid vaccine will be priced competitively, says company

Gemcovac does not require sub-zero temperatures for storage and transport, unlike two other international doses

Centre asks states to step up surveillance to curb Covid-19 spread

States have been asked to screen 2 per cent of international travellers randomly with RT-PCR tests and send all positive samples for genomic sequencing

Delayed diagnosis, reluctance to take booster dose pushing severe cases up

Patients are turning up many days after onset of symptoms, say doctors

India's first indigenous mRNA vax Gemcovac-19 likely to be available soon

Gennova Biopharmaceuticals Ltd aims to produce around 4 - 5 million doses per month and this capacity can be quickly doubled

MoH asks states to prepare for upcoming Yatras, contain Covid-19 spread

Calls for managing crowds at Amarnath, Chardham and other yatras, where large gatherings could help spread Covid-19 and other diseases

Glenmark acquires Wockhardt's key OTC brands in US for undisclosed sum

Deal includes approved ANDAs for famotidine tablets, used in treatment and prevention of ulcers stomach and intestinal ulcers

India's first indigenous mRNA vaccine likely to be available soon

The Subject Expert Committee (SEC) has recommended granting the Emergency Use Authorisation (EUA) to the country's first mRNA-based Covid-19 vaccine in a meeting held on Friday

India sitting on 500 million syringe inventory as demand goes down

The government has also cancelled several orders of various manufacturers giving quality reasons

Expert panel approves use of Serum Institute's Covovax for 7-11-year olds

India started vaccinating adolescents (aged 15-18) from January, and further expanded the drive to include children as young as 12 years from March

Dr Reddy's Laboratories eyes place among top five domestic pharma players

The US would continue to remain an important geography, but the firm says it hopes to double its revenues from China and grow revenues five-fold in Brazil in the next five years

Step up Covid-19 testing and genome sequencing: Mansukh Mandaviya

India reported 13,313 new cases in the last 24 hours and the active caseload currently stands at 83,990

18% people in India reinfected with Covid-19 in last 6 months: Survey

Around 46 per cent of those surveyed said their second infection was more severe than the first one